Are NETs a Novel, Exciting, Thrombosis Risk Marker?

Guozheng Wang; Simon Timothy Abrams; Cheng-Hock Toh

doi:10.1055/a-2187-0645

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2024; 124(05): 455-458
DOI: 10.1055/a-2187-0645

Invited Editorial Focus

Are NETs a Novel, Exciting, Thrombosis Risk Marker?

Authors

Guozheng Wang

¹Department of Clinical Infection, Microbiology and Immunology, University of Liverpool, Liverpool, United Kingdom

²Department of Haematology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom
Simon Timothy Abrams

¹Department of Clinical Infection, Microbiology and Immunology, University of Liverpool, Liverpool, United Kingdom

²Department of Haematology, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom
Cheng-Hock Toh

¹Department of Clinical Infection, Microbiology and Immunology, University of Liverpool, Liverpool, United Kingdom

³Roald Dahl Haemostasis & Thrombosis Centre, Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom

Abstract

Full Text

References

References
1 Chao TF, Joung B, Takahashi Y. et al. 2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: executive summary. Thromb Haemost 2022; 122 (01) 20-47
2 Romiti GF, Pastori D, Rivera-Caravaca JM. et al. Adherence to the ‘Atrial Fibrillation Better Care’ pathway in patients with atrial fibrillation: impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients. Thromb Haemost 2022; 122 (03) 406-414
3 Liu X, Li X, Xiong S. et al. Neutrophil extracellular traps: potential prothrombotic state markers and therapeutic targets for atrial fibrillation. Thromb Haemost 2024; 124 (05) 441-454
4 Takei H, Araki A, Watanabe H, Ichinose A, Sendo F. Rapid killing of human neutrophils by the potent activator phorbol 12-myristate 13-acetate (PMA) accompanied by changes different from typical apoptosis or necrosis. J Leukoc Biol 1996; 59 (02) 229-240
5 Brinkmann V, Reichard U, Goosmann C. et al. Neutrophil extracellular traps kill bacteria. Science 2004; 303 (5663) 1532-1535
6 Brinkmann V, Zychlinsky A. Neutrophil extracellular traps: is immunity the second function of chromatin?. J Cell Biol 2012; 198 (05) 773-783
7 Martinod K, Wagner DD. Thrombosis: tangled up in NETs. Blood 2014; 123 (18) 2768-2776
8 Shaw RJ, Abrams ST, Austin J. et al. Circulating histones play a central role in COVID-19-associated coagulopathy and mortality. Haematologica 2021; 106 (09) 2493-2498
9 Shaw RJ, Bradbury C, Abrams ST, Wang G, Toh CH. COVID-19 and immunothrombosis: emerging understanding and clinical management. Br J Haematol 2021; 194 (03) 518-529
10 Rohrbach AS, Slade DJ, Thompson PR, Mowen KA. Activation of PAD4 in NET formation. Front Immunol 2012; 3: 360
11 Papayannopoulos V. Neutrophil extracellular traps in immunity and disease. Nat Rev Immunol 2018; 18 (02) 134-147
12 Kenny EF, Herzig A, Krüger R. et al. Diverse stimuli engage different neutrophil extracellular trap pathways. eLife 2017; 6: 6
13 Alhamdi Y, Abrams ST, Cheng Z. et al. Circulating histones are major mediators of cardiac injury in patients with sepsis. Crit Care Med 2015; 43 (10) 2094-2103
14 Alhamdi Y, Zi M, Abrams ST. et al. Circulating histone concentrations differentially affect the predominance of left or right ventricular dysfunction in critical illness. Crit Care Med 2016; 44 (05) e278-e288
15 Fuchs TA, Brill A, Duerschmied D. et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A 2010; 107 (36) 15880-15885
16 Laridan E, Martinod K, De Meyer SF. Neutrophil extracellular traps in arterial and venous thrombosis. Semin Thromb Hemost 2019; 45 (01) 86-93
17 Abrams ST, Su D, Sahraoui Y. et al. Assembly of alternative prothrombinase by extracellular histones initiates and disseminates intravascular coagulation. Blood 2021; 137 (01) 103-114
18 Alhamdi Y, Abrams ST, Lane S, Wang G, Toh CH. Histone-associated thrombocytopenia in patients who are critically ill. JAMA 2016; 315 (08) 817-819
19 Abrams ST, Zhang N, Manson J. et al. Circulating histones are mediators of trauma-associated lung injury. Am J Respir Crit Care Med 2013; 187 (02) 160-169
20 Yong J, Abrams ST, Wang G, Toh CH. Cell-free histones and the cell-based model of coagulation. J Thromb Haemost 2023; 21 (07) 1724-1736
21 Ammollo CT, Semeraro F, Xu J, Esmon NL, Esmon CT. Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation. J Thromb Haemost 2011; 9 (09) 1795-1803
22 Swystun LL, Mukherjee S, Liaw PC. Breast cancer chemotherapy induces the release of cell-free DNA, a novel procoagulant stimulus. J Thromb Haemost 2011; 9 (11) 2313-2321
23 Varjú I, Longstaff C, Szabó L. et al. DNA, histones and neutrophil extracellular traps exert anti-fibrinolytic effects in a plasma environment. Thromb Haemost 2015; 113 (06) 1289-1298
24 Huang H, Chen HW, Evankovich J. et al. Histones activate the NLRP3 inflammasome in Kupffer cells during sterile inflammatory liver injury. J Immunol 2013; 191 (05) 2665-2679
25 Beltrán-García J, Osca-Verdegal R, Pérez-Cremades D. et al. Extracellular histones activate endothelial NLRP3 inflammasome and are associated with a severe sepsis phenotype. J Inflamm Res 2022; 15: 4217-4238
26 Lam FW, Cruz MA, Parikh K, Rumbaut RE. Histones stimulate von Willebrand factor release in vitro and in vivo. Haematologica 2016; 101 (07) e277-e279
27 Mutua V, Gershwin LJ. A review of neutrophil extracellular traps (NETs) in disease: potential anti-NETs therapeutics. Clin Rev Allergy Immunol 2021; 61 (02) 194-211
28 Blasco A, Coronado MJ, Vela P. et al. Prognostic implications of neutrophil extracellular traps in coronary thrombi of patients with ST-elevation myocardial infarction. Thromb Haemost 2022; 122 (08) 1415-1428
29 Bianchini EP, Razanakolona M, Helms J. et al. The proteolytic inactivation of protein Z-dependent protease inhibitor by neutrophil elastase might promote the procoagulant activity of neutrophil extracellular traps in sepsis. Thromb Haemost 2022; 122 (04) 506-516
30 Chen JW, Hsu CC, Su CC. et al. Transient bacteremia promotes catheter-related central venous thrombosis through neutrophil extracellular traps. Thromb Haemost 2022; 122 (07) 1198-1208
31 Wang Y, Li M, Stadler S. et al. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol 2009; 184 (02) 205-213
32 Parker H, Winterbourn CC. Reactive oxidants and myeloperoxidase and their involvement in neutrophil extracellular traps. Front Immunol 2013; 3: 424
33 Farrera C, Fadeel B. Macrophage clearance of neutrophil extracellular traps is a silent process. J Immunol 2013; 191 (05) 2647-2656
34 Englert H, Göbel J, Khong D. et al. Targeting NETs using dual-active DNase1 variants. Front Immunol 2023; 14: 1181761
35 Kuipers S, Klein Klouwenberg PM, Cremer OL. Incidence, risk factors and outcomes of new-onset atrial fibrillation in patients with sepsis: a systematic review. Crit Care 2014; 18 (06) 688
36 Wallenhorst C, Martinez C, Freedman B. Risk of ischemic stroke in asymptomatic atrial fibrillation incidentally detected in primary care compared with other clinical presentations. Thromb Haemost 2022; 122 (02) 277-285
37 Abrams ST, Morton B, Alhamdi Y. et al. A novel assay for neutrophil extracellular trap formation independently predicts disseminated intravascular coagulation and mortality in critically ill patients. Am J Respir Crit Care Med 2019; 200 (07) 869-880